Emily Gibbons

621 total citations
21 papers, 137 citations indexed

About

Emily Gibbons is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Emily Gibbons has authored 21 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 4 papers in Rheumatology. Recurrent topics in Emily Gibbons's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (9 papers) and Cardiac Arrest and Resuscitation (3 papers). Emily Gibbons is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (9 papers) and Cardiac Arrest and Resuscitation (3 papers). Emily Gibbons collaborates with scholars based in United Kingdom, United States and United Arab Emirates. Emily Gibbons's co-authors include Saif Huda, Patrick Waters, Michael C. Kurz, Ashish R. Panchal, Chiara Rocchi, Anu Jacob, James Mitchell, Mark Woodhall, Shahd Hamid and Mark Woodhall and has published in prestigious journals such as New England Journal of Medicine, Circulation and Cochrane Database of Systematic Reviews.

In The Last Decade

Emily Gibbons

19 papers receiving 134 citations

Peers

Emily Gibbons
Serkan Demir Türkiye
Nyoman Golden Indonesia
Okacha Naama Morocco
Giovanna S. Manzano United States
Robert Almeyda United Kingdom
David Ledingham United Kingdom
Serkan Demir Türkiye
Emily Gibbons
Citations per year, relative to Emily Gibbons Emily Gibbons (= 1×) peers Serkan Demir

Countries citing papers authored by Emily Gibbons

Since Specialization
Citations

This map shows the geographic impact of Emily Gibbons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Gibbons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Gibbons more than expected).

Fields of papers citing papers by Emily Gibbons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Gibbons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Gibbons. The network helps show where Emily Gibbons may publish in the future.

Co-authorship network of co-authors of Emily Gibbons

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Gibbons. A scholar is included among the top collaborators of Emily Gibbons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Gibbons. Emily Gibbons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rocchi, Chiara, et al.. (2025). Is a Benign Disease Course Possible in Untreated AQP4IgG NMOSD?. European Journal of Neurology. 32(3). e70049–e70049. 3 indexed citations
2.
Manzano, Giovanna S., Michaël Levy, Farrah J. Mateen, et al.. (2024). Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes. Journal of Neurology. 271(9). 6160–6171. 5 indexed citations
3.
Rocchi, Chiara, et al.. (2024). Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort study. Multiple Sclerosis and Related Disorders. 83. 105452–105452. 3 indexed citations
4.
Rocchi, Chiara, Patricia A. Kelly, Samantha Linaker, et al.. (2024). The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis. Multiple Sclerosis Journal. 30(3). 345–356. 1 indexed citations
5.
Gibbons, Emily, Jeffrey Yu, Karissa Johnston, et al.. (2024). Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder. Annals of Clinical and Translational Neurology. 11(7). 1942–1947. 4 indexed citations
6.
Rocchi, Chiara, Emily Gibbons, Mark Woodhall, et al.. (2023). Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria. Neurology Neuroimmunology & Neuroinflammation. 11(1). 24 indexed citations
7.
Lotan, Itay, John J. Chen, Yael Hacohen, et al.. (2023). Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease. Multiple Sclerosis Journal. 29(9). 1080–1089. 13 indexed citations
8.
Yang, Betty, et al.. (2022). State Requirements for Medical Directors in the United States. Prehospital Emergency Care. 27(6). 786–789. 1 indexed citations
9.
Gibbons, Emily, et al.. (2022). Knowledge, Attitudes, and Beliefs of Pediatric Health Care Workers: Understanding the Response to COVID-19. Journal of Pediatric Health Care. 36(4). 305–309.
10.
Gibbons, Emily, Daniel Whittam, Maneesh Bhojak, et al.. (2022). Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy. Multiple Sclerosis Journal. 28(9). 1481–1484. 4 indexed citations
11.
Gibbons, Emily, Daniel Whittam, Anu Jacob, & Saif Huda. (2021). Images of the month 1: Trident sign and neurosarcoidosis. Clinical Medicine. 21(6). e667–e668. 3 indexed citations
12.
Whittam, Daniel, et al.. (2021). A case series of intracranial dural arteriovenous fistulae mimicking cervical myelitis: a diagnosis not to be missed. Journal of Neurology. 268(12). 4680–4686. 7 indexed citations
13.
Gibbons, Emily, et al.. (2021). Treatment of myelin oligodendrocyte glycoprotein immunoglobulin G–associated disease. Clinical and Experimental Neuroimmunology. 12(1). 22–41. 12 indexed citations
14.
Gibbons, Emily, et al.. (2021). The characterisation of sleep and circadian rhythm in neuromyelitis optica. Medical Research Archives. 9(10). 1 indexed citations
15.
Woodhall, Mark, et al.. (2020). Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19. Frontiers in Neurology. 11. 598531–598531. 23 indexed citations
16.
James, Eleanor, et al.. (2020). Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis. Cochrane Database of Systematic Reviews. 1 indexed citations
17.
18.
Gibbons, Emily, et al.. (2019). PNS385 USING THE VARK MODEL TO AID QUALITATIVE DATA COLLECTION IN PEDIATRIC PATIENTS. Value in Health. 22. S830–S830.
19.
Panchal, Ashish R., et al.. (2016). Abstract 17361: Low Dose- High Frequency, Case Based Psychomotor CPR Training Improves Compression Fraction for Patients With In-hospital Cardiac Arrest. Circulation. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026